Jan 12, 2026 01:45PM
Sep 26, 2025 05:08AM
Jun 4, 2025 07:00AM
Dec 17, 2024 05:10AM
Jun 5, 2024 07:00AM
Dec 28, 2023 07:00AM
Nov 9, 2023 06:28AM Goldman Sachs Starts Apellis Pharmaceuticals (APLS) at Buy
Jun 7, 2023 07:00AM
Feb 27, 2023 05:19PM
Feb 27, 2023 05:19PM
Feb 23, 2023 05:45AM
Feb 22, 2023 09:48PM
Feb 22, 2023 09:48PM
Feb 22, 2023 07:23AM Apellis Pharmaceuticals (APLS) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Feb 22, 2023 07:22AM
Feb 22, 2023 07:22AM
Oct 17, 2022 12:33PM
Aug 9, 2022 03:59AM
Jun 1, 2022 04:05PM
Jun 1, 2022 04:05PM
Mar 28, 2022 04:01PM Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Mar 28, 2022 04:01PM
Mar 24, 2022 07:00AM
Mar 24, 2022 07:00AM
Mar 24, 2022 07:00AM
Mar 23, 2022 04:03PM
Mar 23, 2022 04:02PM
Mar 23, 2022 04:02PM Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Mar 1, 2022 07:40AM
Jan 6, 2022 12:37PM
Nov 18, 2021 04:01PM
Nov 18, 2021 04:01PM
Nov 16, 2021 07:00AM
Nov 16, 2021 07:00AM
Nov 16, 2021 07:00AM Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Nov 15, 2021 04:01PM
Nov 15, 2021 04:01PM
Nov 15, 2021 04:01PM
Nov 12, 2021 11:29AM
Jun 3, 2021 07:00AM
Jun 3, 2021 07:00AM
May 17, 2021 12:53PM Apellis Pharmaceuticals (APLS) PT Raised to $143 at Goldman Sachs, Following Clinical Business Update
Apr 16, 2021 09:26AM
Apr 16, 2021 04:12AM
Jun 4, 2020 07:00AM
Jun 4, 2020 07:00AM
Jan 7, 2020 09:30AM
Apr 17, 2018 09:22AM

184,605 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All